Tuesday | Molecular Therapy
Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages...
Jonas H Graversen 1 , Pia Svendsen 1 , 2 , Frederik Dagnæs-Hansen 2 , Jakob Dal 2 , Gabriele Anton 1 , Anders Etzerodt 2 , Mikkel D Petersen 2 , Peter A Christensen 1 , 3 , Holger J Møller 3 and Søren K Moestrup 2 , 3 Correspondence: Søren K Moestrup, Department of Biomedicine, Aarhus University, Ole Worms Alle 3, ... (more)
Celtic Pharma Announces Successful Completion of Phase I/II study of...
NEW YORK, LONDON & HAMILTON, Bermuda -- -- Celtic Pharmaceutical Holdings L.P. , a global private equity firm focused on late stage pharmaceutical assets, announces that it has completed a successful Phase I/II study of the investigational new drug Xerecept A in pediatric patients who are dependent on the steroid Decadron to treat peritumoral brain ... (more)
tobramycin and dexamethasone, Tobradex, Tobradex ST
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
In vivo imaging of lymphatic vessels in development, wound healing,...
Proceedings of the National Academy of Sciences of the United States of America , doi:10.1073/pnas.1115542109 Lymphatic vessel growth or lymphangiogenesis occurs during embryonic development and wound healing and plays an important role in tumor metastasis and inflammatory diseases.
Also on Topix